PTH news

Latest 1 stories · newest Nov 12, 2026

PTH

Pelthos reports Q3 '26 financial results; net product revenue up 114%

Pelthos Therapeutics announced Q3 2026 financial results showing $15.2 million in net product revenue for Zelsuvmi, driven by significant growth and a strategic merger with Castle Creek. The company expects to expand growth with upcoming product launches in 2027.

Earnings|Other Nov 12, 2026 sentiment +0.80 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same PTH feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/PTH/newsSTART FREE